Are you Dr. Nakagawa?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 33 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4301 W Markham St
# 783
Little Rock, AR 72205Phone+1 501-686-8000
Summary
- Dr. Mayumi Nakagawa, MD is a board certified pathologist in Little Rock, Arkansas. She is currently licensed to practice medicine in Arkansas and California. She is affiliated with UAMS Medical Center and is an Associate Professor at University of Arkansas COM.
Education & Training
- University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 1990 - 1992
- Albert Einstein College of MedicineClass of 1990
Certifications & Licensure
- AR State Medical License 2004 - 2025
- CA State Medical License 1992 - 2025
- American Board of Pathology Clinical Pathology
Clinical Trials
- Study With Candida Antigen for Treatment of Warts Start of enrollment: 2007 Feb 01
- A Phase I Clinical Trial of an HPV Therapeutic Vaccine Start of enrollment: 2012 Aug 01
Publications & Presentations
PubMed
- Coinfections with additional oncoviruses in HPV+ individuals: Status, function and potential clinical implications.Lu Dai, Lillie G Wilson, Mayumi Nakagawa, Zhiqiang Qin
Journal of Medical Virology. 2024-01-01 - 1 citationsAssessing the Feasibility of an Online Module for Promoting Cancer Prevention Measures.Sumit K. Shah, Brittany E. Demmings, Milan Bimali, Kristie B. Hadden, Mayumi Nakagawa
Cancer Control. 2021-11-18 - 6 citationsExpansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion...Takeo Shibata, Sumit K. Shah, Teresa Evans, Hannah N. Coleman, Benjamin J. Lieblong
Frontiers in Immunology. 2021-09-30
Press Mentions
- UAMS Doctor Working on HPV CureMarch 23rd, 2016
- UAMS Researcher’s HPV Vaccine Holds Promise for Saving Lives, Preventing Premature BirthsMarch 9th, 2016
Grant Support
- Understanding And Enhancing T-Cell Responses To High Risk Human PapillomavirusesNational Cancer Institute2010–2012
- Cytotoxic T Lymphocyte Response To HPV 16National Cancer Institute1998–2002